📚 Extracted Documents

This document is a publication list from the Indian Drug Manufacturers' Association (IDMA), detailing various bulletins and journal subscriptions offered to members and non-members. It includes pricing, subscription details, and contact information for obtaining these publications. The document provides an overview of the available publications and their corresponding costs as of September 4, 2025.

The document appears to be a general PDF document or report, possibly related to the user's interests in the IDMA news feed. It doesn't specify a clear category like advisory or press release but serves as a catch-all for unspecified documents. This document may contain information relevant to the user's interests, despite lack of specificity in category.

This document is an English reference guide for the Chhattisgarh Industrial Development Policy 2024-30, issued by the Department of Commerce and Industries, Government of Chhattisgarh. It outlines the policy's vision, objectives, and provisions aimed at fostering industrial growth in the region by leveraging local resources and promoting emerging sectors. It includes detailed sections on different industrial packages and incentives for various sectors and enterprise sizes.

This is a report titled 'Future Pandemic Preparedness and Emergency Response: A Framework for Action' from NITI Aayog's Expert Group, providing recommendations on governance, data management, and public health strategies. The document compiles lessons learned from past pandemics, challenges of COVID-19, and future threats with insights from notable experts including Dr. Renu Swarup and Dr. Soumya Swaminathan. It outlines key recommendations in areas like data management, regulatory reforms, and community engagement.

This document is a report from an expert group on future pandemic preparedness and emergency response, supported by NITI Aayog and including high-profile members like Dr. Renu Swarup and Dr. Soumya Swaminathan. It includes sections on lessons from past epidemics, COVID-19 learnings, and provides recommendations on governance, data management, and community engagement. The document's main focus is on forming a framework for action to improve readiness for future health emergencies.

This document outlines a survey initiative by the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, to map and analyze the domestic Active Pharmaceutical Ingredients (API) industry in India. The survey aims to assess the industry's capacity, production capabilities, import dependencies, and market size to advance the pharmaceutical sector. M/S SR Asia is conducting the study to provide insights for better policy-making and sector growth support.

This document is a public invitation by the Government of India's Department of Scientific & Industrial Research for proposals under the PACE Scheme. It seeks applications from registered Indian companies for funding innovative technology projects. Detailed eligibility criteria and application guidelines are provided, with a submission deadline of August 29, 2022.

This document outlines the guidelines for the Patent Acquisition and Collaborative Research and Technology Development (PACE) scheme by the Department of Scientific and Industrial Research, Ministry of Science & Technology of the Government of India. The scheme aims to support industries and academic institutions in developing and demonstrating new technologies for commercialization, excluding biotechnology and software as a service. The document includes eligibility criteria, funding mechanisms, and operative procedures to promote collaborative research and technology development in India.

This IDMA Bulletin discusses legal and regulatory updates relevant to the pharmaceutical industry. It includes a summary of a High Court order that affects the working hours of Medical Representatives in Bihar and addresses regulatory compliance concerning Methylcobalamin formulations. The document reflects IDMA's engagement and advocacy in ongoing legal issues impacting member companies.

This document is an FAQ on the implementation of GSR 823(E) related to Bar Code and QR Code requirements for the top 300 drug brands, effective from August 1, 2023. It explains the requirements for affixing Barcodes or QR Codes, their applicability, and additional guidance for manufacturers, including procedures for importing products with such codes. The document addresses how these changes affect both domestic and foreign manufacturers.

This document is a FAQ guide on the implementation of the GSR 823(E) notification, dated November 17, 2022, regarding the affixing of Barcodes or QR codes on the top 300 drug brands. It explains the requirements, effective date of August 1, 2023, and applicability for manufacturers both domestic and international. It also addresses practical issues such as space constraints on labels and the process for imported products.

This is a registration form from the Indian Drug Manufacturers’ Association (IDMA) for the 24th Pharmaceutical Analysts’ Convention scheduled for December 2025 in Mumbai. It includes details about the convention, registration fees for various categories, payment methods, and group registration benefits. Participants are asked to fill out their details and make payments to secure their registration.

This document provides guidelines and application format for the Patent Acquisition and Collaborative Research and Technology Development (PACE) scheme by the Department of Scientific and Industrial Research, Ministry of Science & Technology, Government of India. The PACE initiative aims to support industries and institutions in developing and demonstrating innovative technologies. It includes details on eligibility criteria, the scope of the scheme, supported activities, and funding mechanisms.

This document outlines the appointment of the Ethics Committee for Pharmaceutical Marketing Practices by the IDMA. It lists the newly nominated committee members, appointed during an Executive Committee Meeting on March 22, 2024, for a span of five years. The members belong to various pharmaceutical companies, including Saga Lifesciences and Strassenburg Pharmaceuticals.

This document is the IDMA Bulletin covering the 61st Annual General Meeting and Annual Day Celebrations of the Indian Drug Manufacturers' Association (IDMA), held in February 2023 in Mumbai. It includes reports and speeches from key industry figures, discussions on membership retention, and deliberations on the Indian pharmaceutical industry's global impact and future growth opportunities. The document highlights various sessions and events from the meeting, including the release of IDMA's annual publication and various awards and recognitions.

This document is a registration form for the 24th Pharmaceutical Analysts’ Convention hosted by the Indian Drug Manufacturers’ Association. It details the process for registering participants, fees, and payment methods for the event scheduled in December 2025. It is primarily aimed at company representatives interested in attending the conference.

This document is the IDMA Bulletin for January 1-7, 2022, issued by the Indian Drug Manufacturers' Association. It features a variety of articles and updates relevant to the pharmaceutical industry, including discussions on COVID-19, AI usage in pharma, and export strategies. The document also informs about the postponement of IDMA's 60th Annual Day celebrations due to COVID-19 concerns.

This document, issued by the Indian Drug Manufacturers' Association (IDMA), includes an update on the regulation of methylcobalamin in health supplements and a summary of a significant High Court ruling regarding the working hours of medical representatives in Bihar. The court ruled against the government's notification to set specific work hours, emphasizing flexibility needed in the pharmaceutical field. The IDMA advocates continuous dialogue with authorities on these matters.

This document provides a brief overview of ARaymond, a company specializing in healthcare packaging and medical devices. It highlights their expertise in plastic processing and introduces their product RayDyLyo® – a plastic press-fit closure for injectable vials. The document also mentions their participation as a first-time exhibitor at an upcoming event in November 2025 in Delhi.